Microbiome Insights, Inc. is a leading global provider of end-to-end services for microbiome DNA sequencing, including state-of-the-art bioinformatic analysis. Based in Vancouver, Canada, the company's customized suite of services enables researchers and clinicians to easily and effectively include microbiome analysis in studies across a range of human, animal, agricultural and environmental applications.

Semios is the leader in onsite sensing, big data and predictive analytics solutions for perennial agricultural crops. The Semios platform is a powerful tool in yield improvement that enables growers to assess and respond to insect, disease and plant health conditions in real-time. www.semios.com

Teach Business of Biotech course as part of the Management of Technology MBA program.

Sherpa Foods is a Social Purpose Corporation and a Certified B Corp Pending Company, committed to preserving the rich cultural traditions of the Himalayas by sharing our beloved foods with the rest of the world. Sherpa Foods makes and sells "Tsampa", a nutritious ancient whole grain cereal that is delicious and provides long lasting energy. Made from sprouted and roasted barley, it’s naturally high in dietary fiber and beta-glucan. Sherpa Foods uses traditional methods when preparing its Tsampa, including ancient sprouting and roasting techniques, which produces a nutritious whole food with a special wholesome nutty flavor.

Indel Therapeutics Inc. was a biopharmaceutical company developing new drugs to address the global health crisis caused by antibiotic resistance. The Company had a pipeline of novel antibiotic drug discovery programs that focus on curing difficult-to-treat and hospital-acquired infections. These programs were based on Indel’s paradigm-changing antimicrobial drug discovery platform, a patented technology that has opened a rich, new area of drug targets for the treatment of bacterial and parasitic infections and, potentially, fungal and viral infections.

Canadian and U.S-based advisory firm that provide financial strategy and business development consulting services to North American and Asian life science companies.

Inimex Pharmaceuticals Inc. was focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body’s innate defenses without causing inflammation. The Company was acquired by Soligenix, Inc. in 2012.

Member of the investment team of a leading North American life science venture capital company with more than $1 billion under management. Responsible for sourcing, evaluating, investing in emerging life science companies. Managed a portfolio of 8 companies that focused on infectious disease, cancer therapeutics, inflammatory disease, systemic delivery of siRNA, regenerative medicine and cell therapies. Served on three boards. Actively involved in developing corporate strategy, recruiting senior management and directors, and corporate governance.

Part of team that attempted to form a new $120 million life science venture capital fund to invest in clinical stage biotech and medical device companies.

Taught course on venture capital valuation and deal structure as part of top 20 MBA program.

Member of the investment team of one of the most active and experienced venture funds in the Southeast – founded in 1985, Intersouth manages $780 million and has invested in more than 90 private companies. Responsible for sourcing, evaluating and conducting due diligence on investment opportunities, as well as the monitoring of investments. Worked as part of team negotiating and structuring deals, building syndicates, hiring key management and managing the life cycle of each investment. Led two new investments and was involved in 18 early stage financings that raised $82 million. Participated at Board level with five portfolio companies. Focused on life science technology transfer companies from Duke, UNC and NCSU.

Hired by the Board of Directors to turn around a start-up company that designed, manufactured and marketed multifunctional computer peripherals. Involved in critical decisions and policy making with the Board of Directors. Secured company's financing, developed capital strategy, maintained budgets, and managed relationships with venture capital investors, directors and other shareholders. Led team of six engineers and programmers to create company's flagship product.

Responsible for all marketing, public relations and advertising for a start-up manufacturer of HP and Canon compatible printer and copier toner cartridges. As senior executive, helped grow sales from $200,000 to $23.7 million in four years. Active shareholder and participant on the Board of Directors.

Led elite Special Forces detachments in foreign internal defense, military freefall parachuting and special reconnaissance operations in Southeast Asia (3rd Battalion, 1st Special Forces Group). Second in command of 300-person unit that provided all operational, logistical and administrative support to 1,000-person Infantry battalion. Supervised 80-person maintenance operation for 206 combat vehicles. Commanded mechanized infantry and anti-tank platoons (3/36 Infantry, 3rd Amored Division, Germany). Airborne, Ranger and Special Forces qualified. My formative years...